<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-30T03:51:11Z</responseDate><request verb="GetRecord" identifier="oai:repisalud.isciii.es:20.500.12105/17074" metadataPrefix="mets">https://repisalud.isciii.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:repisalud.isciii.es:20.500.12105/17074</identifier><datestamp>2024-11-28T14:48:47Z</datestamp><setSpec>com_20.500.12105_15322</setSpec><setSpec>com_20.500.12105_2051</setSpec><setSpec>col_20.500.12105_16927</setSpec></header><metadata><mets xmlns="http://www.loc.gov/METS/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" ID="&#xa;&#x9;&#x9;&#x9;&#x9;DSpace_ITEM_20.500.12105-17074" TYPE="DSpace ITEM" PROFILE="DSpace METS SIP Profile 1.0" xsi:schemaLocation="http://www.loc.gov/METS/ http://www.loc.gov/standards/mets/mets.xsd" OBJID="&#xa;&#x9;&#x9;&#x9;&#x9;hdl:20.500.12105/17074">
   <metsHdr CREATEDATE="2026-04-30T05:51:11Z">
      <agent ROLE="CUSTODIAN" TYPE="ORGANIZATION">
         <name>Repisalud</name>
      </agent>
   </metsHdr>
   <dmdSec ID="DMD_20.500.12105_17074">
      <mdWrap MDTYPE="MODS">
         <xmlData xmlns:mods="http://www.loc.gov/mods/v3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
            <mods:mods xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Boto-Ordóñez, María</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Urpi-Sarda, Mireia</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Queipo-Ortuño, María Isabel</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Tulipani, Sara</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Tinahones, Francisco J</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Andrés-Lacueva, Cristina</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">authoraffiliation</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>[Boto-Ordóñez, M; Urpi-Sarda,M; Tulipani, S; Andrés-Lacueva,C] Biomarkers  and  Nutritional  &amp;  Food  Metabolomics  Research  Group,  Nutrition  and Food Science Department, XaRTA, INSA, Pharmacy Faculty, University of Barcelona, Spain. [Queipo-Ortuño, MI; Tulipani, S] Research  Laboratory,  IMABIS  Foundation,  Virgen  de  la  Victoria  Clinical  Hospital, Málaga, Spain. [Queipo-Ortuño, MI; Tinahones, FJ] CIBER  Fisiopatología  de  la  Obesidad  y  la  Nutrición,  Instituto  de  Salud  Carlos  III, Madrid, Spain. [Tinahones, FJ] Servicio  Endocrinología  y  Nutrición  del  Hospital  Universitario  Virgen  de  la  Victoria, Málaga, Spain.</mods:namePart>
               </mods:name>
               <mods:extension>
                  <mods:dateAccessioned encoding="iso8601">2024-01-15T18:17:21Z</mods:dateAccessioned>
               </mods:extension>
               <mods:extension>
                  <mods:dateAvailable encoding="iso8601">2024-01-15T18:17:21Z</mods:dateAvailable>
               </mods:extension>
               <mods:originInfo>
                  <mods:dateIssued encoding="iso8601">2014-08</mods:dateIssued>
               </mods:originInfo>
               <mods:identifier type="doi">10.1039/c4fo00029c</mods:identifier>
               <mods:identifier type="e-issn">2042-650X</mods:identifier>
               <mods:identifier type="issn">2042-6496</mods:identifier>
               <mods:identifier type="journal">Food &amp; Function</mods:identifier>
               <mods:identifier type="other">http://hdl.handle.net/10668/2101</mods:identifier>
               <mods:identifier type="pubmedID">24958563</mods:identifier>
               <mods:identifier type="uri">http://hdl.handle.net/20.500.12105/17074</mods:identifier>
               <mods:abstract>The health benefits associated with the consumption of polyphenol-rich foods have been studied in depth, however, the full mechanism of action remains unknown. One of the proposed mechanisms is through microbiota interaction. In the present study, we aimed to explore the relationship between changes in fecal microbiota and changes in urinary phenolic metabolites after wine interventions. Nine participants followed a randomized, crossover, controlled interventional trial. After the washout period, they received red wine, dealcoholized red wine or gin for 20 days each. Polyphenol metabolites (n > 60) in urine were identified and quantified by UPLC-MS/MS and the microbial content of fecal samples was quantified by real-time quantitative PCR. Interventions with both red wine and dealcoholized red wine increased the fecal concentration of Bifidobacterium, Enterococcus and Eggerthella lenta, compared to gin intervention and baseline. When participants were categorized in tertiles of changes in fecal bacteria, those in the highest tertile of Bifidobacteria had higher urinary concentration changes in syringic acid, p-coumaric acid, 4-hydroxybenzoic acid and homovanillic acid (all anthocyanin metabolites) than those in tertile 1 (P &lt; 0.05, all). In addition, changes of Bifidobacteria correlated positively with changes of these metabolites (r = 0.5-0.7, P &lt; 0.05, all). Finally, the 68.5% changes in Bifidobacteria can be predicted by syringic acid and 4-hydroxybenzoic acid changes. This study confirms the important role of polyphenols as bacterial substrates and their modulatory capacity as an important field in the research of new products with prebiotic and probiotic characteristics for the food industry.</mods:abstract>
               <mods:language>
                  <mods:languageTerm authority="rfc3066">eng</mods:languageTerm>
               </mods:language>
               <mods:accessCondition type="useAndReproduction"/>
               <mods:subject>
                  <mods:topic>Wine</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Microbiota</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Bifidobacteria</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Anthocyanins</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>in vivo</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>prebiotic</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Heces</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Polifenoles</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Vino</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Bifidobacteria</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Antocianinas</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Fenómenos fisiológicos de la nutrición</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Tracto gastrointestinal</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Contenido digestivo</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Marcadores biológicos</mods:topic>
               </mods:subject>
               <mods:titleInfo>
                  <mods:title>High levels of Bifidobacteria are associated with increased levels of anthocyanin microbial metabolites: a randomized clinical trial.</mods:title>
               </mods:titleInfo>
               <mods:genre>research article</mods:genre>
            </mods:mods>
         </xmlData>
      </mdWrap>
   </dmdSec>
   <structMap LABEL="DSpace Object" TYPE="LOGICAL">
      <div TYPE="DSpace Object Contents" ADMID="DMD_20.500.12105_17074"/>
   </structMap>
</mets></metadata></record></GetRecord></OAI-PMH>